STOCK TITAN

Director of BLMH (NASDAQ: BLMH) awarded 64,082 shares as compensation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BioLife Holdings, Inc. reported a director stock award. Director Bradley Laurence Hirsch received 64,082 shares of common stock on December 31, 2025, as compensation for his service on the board. The implied price was $0.98 per share, and he now beneficially owns 64,082 shares directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HIRSCH BRADLEY LAURENCE

(Last) (First) (Middle)
11516 DOWNEY AVE

(Street)
DOWNEY CA 90241

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BLUM HOLDINGS, INC. [ BLMH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2025 A 64,082 A(1) $0.98 64,082 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares reported herein were issued to Bradley Hirsch on December 31, 2025 as compensation for service as a director of the Issuer, at an implied price of $0.98 per share.
/s/ Bradley Hirsch 01/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BLMH disclose about director Bradley Hirsch in this Form 4?

BLMH disclosed that director Bradley Laurence Hirsch received 64,082 shares of common stock as compensation. The shares were issued on December 31, 2025, at an implied price of $0.98 per share, and he now directly beneficially owns 64,082 shares.

How many BLMH shares did director Bradley Hirsch acquire?

Director Bradley Hirsch acquired 64,082 shares of BLMH common stock. These shares were issued as compensation for his service as a director, rather than purchased in the market, and represent his entire directly beneficially owned position after the reported transaction.

At what price were Bradley Hirsch’s BLMH shares valued in the grant?

The 64,082 BLMH shares granted to director Bradley Hirsch were valued at an implied price of $0.98 per share. This price is described as implied compensation value rather than a disclosed open-market purchase or sale price in this insider transaction report.

Was the BLMH insider transaction a purchase or compensation grant?

The BLMH insider transaction was a compensation grant, not a market purchase. The company issued 64,082 common shares to director Bradley Hirsch on December 31, 2025 as payment for his board service, at an implied price of $0.98 per share.

How many BLMH shares does Bradley Hirsch own after this transaction?

After this reported transaction, Bradley Hirsch beneficially owns 64,082 BLMH common shares directly. The Form 4 indicates this amount as his total direct holdings following the grant issued on December 31, 2025 as director compensation.

Is Bradley Hirsch’s BLMH ownership direct or through an entity?

Bradley Hirsch’s BLMH holdings reported in this filing are held directly. The Form 4 identifies the ownership form as direct, with 64,082 common shares beneficially owned, and includes no footnote indicating an intermediary entity, trust, or partnership.
Blum Holdings

OTC:BLMH

BLMH Rankings

BLMH Latest News

BLMH Latest SEC Filings

BLMH Stock Data

8.67M
26.41M
34.77%
Pharmaceutical Retailers
Healthcare
Link
United States
Downey